Concomitantly, resistance to release of exercise-inducible factors might also be involved, potentially elucidating, at least in part, why FGF21, follistatin, irisin, and METRNL are frequently increased in patients with obesity and T2DM, even in basal conditions. The gene discussed is FST; the disease is obesity disorder.